Miller, D.M. “The Future of Oncology” in “Cecil Textbook of Medicine, 20th Edition”, W.B. Saunders, Philadelphia, 1996, pp. 1071-1077.* |
Salmon, S.E. et al “The Principles of Cancer Therapy” in “Cecil Textbook of Medicine, 20th Edition”, W.B. Saunders, Philadelphia, 1996, pp. 1036-1049.* |
Balasubramanian, B.N. et al, “Recent Developments in Cancer Cytoxics” in “Annual Reports in Medicinal Chemistry, vol. 33”, Academic Press, San Diego, 1998, pp. 151-159.* |
Miller, D.K., “Regulation of Apoptosis of Members of the ICE Family and the Bcl-2 Family” in “Annual Reports in Medicinal Chemistry, vol. 31”, Academic Press, San Diego, 1996, pp. 249-268.* |
Oltersdorf, T. et al, “The Bcl-2 Family: Targets for the Regulation of Apoptosis” in “Annual Reports in Medicinal Chemistry, vol. 33”, Academic Press, San Diego, 1998, pp. 253-262.* |
Aldrich Chemical Company, Milwaukee, WI, 1192, p. 146, entry 86-165-0.* |
Leif C. Anderson, et al. (1981), “ Diazepam induces mitotic arrest at prometaphase by inhibiting centriolar seperation,” Nature 291: 247-248. |
Lynn Rosenberg, et al. (1981), “Relation of Benzodiazepine Use to the Risk of Selected Cancers: Breast, Large Bowel, Malignant melanoma, Lung, Endometrium, Ovary, Non Hodgkin's Lymphoma, Testis, Hodgkins Disease, Thyroid, and Liver,” Am J Epidemiol 141: 1153-1160. |
Wendy E. Solowey, et al. (1990) “Peripheral-Acting Benzodiazpines Inhibit the Growth of Human Malanoma cells Potentiate the Antiproliferative Activity of Recombinant Human Interferons” Journal of Interferon Research 10: 269-280. |
John C. Reed, et al. (1995) “ BCL-2: Prevention of Apoptosis As A Mechanism Of Drug Resistance,” Drug Resistance In Clinical Oncology and Hematology 9:451-473. |
John C. Reed (1995), “Regulation of Apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance,” Rapid Science Publishers: 541-546. |
Hisako Hashimoto, et al. (1995) “Inhibition of Etoposide (VP-16)-induced DNA Recombination and Mutant Frequency by Bel-2 Protein Overexpression” Cancer Research 55: 4029-4035. |
Burkhard Jansen, et al. (1998), bcl-2 antisense therapy chemosensitizes human melanama in SCID mice, Nature Medicine 4: 232-234. |
Barry A. Bunin, et al. (1994) “ The combinatorial sysnthesis and chemical and biological evaluation of a 1,4-benzodiazepine library,” Proc. Natl. Acad. Sci. 91: 4708-4712. |
Claus Braestrup et al. (1977) Specific benzodiazepie receptors in a rat brain characterized by high-affinity [3H] diazepam binding. |
John F. Tallman, et al. (1980), “ Receptors for the age of anxiety: Pharmacology of the Benzodiazepines” Science 207: 274-281. |
Jie Yang, et al. (1997) “ Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked” Science Magazine 275: 1129-1136. |
Moshe Gavish, et al. “ Role of Peripheral-Type Benzodiazepine Receptors in Steroidogenesis” Clinical Neuropharmacology 20: 473-481. |
Christine Teixeira, et al. (1995), “ Estrogen Promotes Chemotherapeutic Drug Resistance by a Mechanism Involving Bcl-2 Proto-Oncogene Expression in Human Breast Cancer Cells”, Cancer Research 55: 3902-3907. |
Kleinerman, et al. (1984) “Diazepam use and Progression of Breast Cancer” Cancer Research 44: 1223-1225. |
Nobuhiko Miyazawa, et al. (1998) “Assessment of the peripheral benzodiazapine receptors in human gliomas by two methods,” Journal of Neuro-Oncology 38: 19-26. |
Barry A. Bunin, et al. (1996), “ Synthesis and Evaluation of 1, 4-Benzodiazepine Libraries” Methods in Enzymology 267: 448-465. |
Candice E. Crooker, et al. (1996) “ Benzodiazepine-Induced Inhibition of Human Malignant Melonoma (M-6) Cell Growth,” Anticancer research 16: 1259-1264. |
Daniela M. Zisterer, et al. (1997) “ Peripheral-Type Benzodiazpine Receptors” Gen. Pharmac. 3: 305-314. |
Rupnow, et al. (1998) “Direct Evidence that Apoptosis Enhances Tumor Responses to Fractionated Radiotherapy” Cancer Research 58: 1779-1784. |
Toshiyuki, et al. (1992), “ bcl-2 Gene Transfer Increases Relative Resistance of S49.1 and WEHI7.2 Lymphoid Cells to Cell Death and DNA Fragmentation Induced by Glucocorticoids and Multiple Chemotherapeutic Drugs” 52: 5407-5411. |